Maqola

IK930, a novel TEAD inhibitor, sensitizes KRAS and EGFR mutant tumors to oncogene targeted therapy

M. RajurkarIkena Oncology, Translational Research, Boston, USAManuel Sánchez‐MartínIkena Oncology, Translational Research, Boston, USA;D. HidalgoIkena Oncology, Translational Research, Boston, USAN. YoungCellular Research (United States)B. AmidonCellular Research (United States)G. PunkosdyIkena Oncology, In vivo Pharmacology, Boston, USAJ. EcsedyIkena Oncology, Discovery Biology, Boston, USALiwen XuKura Oncology (United States)

European Journal of Cancerjournal2022en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Hippo pathway signaling and YAP/TAZ Cancer-related gene regulation

Identifikatorlar

DOI: 10.1016/s0959-8049(22)00906-6

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba